Pulmonary: Page 2

Leveraging AI to advance pulmonary fibrosis

Yale scientists develop new model to better recognize and manage lung disease progression.

July 9, 2025

Growing vascularized human lung and gut organoids becomes a reality

New research could revolutionize the study of pulmonary disease and treatment for organ failure.

July 2, 2025

A new look at the key driver in the development of pulmonary hypertension

Long noncoding RNA contributes to the progression of the life-threatening disease.

July 2, 2025

Sponsored

Pulmonary drug market forecast

Ascend Media

Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.

April 10, 2025

Cigarette smoke and faulty DNA repair propel lung cancer

Experimental outcomes suggest damage begins early but could be avoided or slowed using XPC marker.

June 24, 2025

Nanoparticles carrying genetic therapies target lung cells

The breakthrough drug delivery system will help treat pulmonary diseases like lung cancer and cystic fibrosis.

June 24, 2025

Lung transplant Composite Allocation Score decreases waitlist mortality rate

Research confirms significantly fewer patients have died or been delisted since the new guidelines were implemented in spring 2023.

June 20, 2025

Sponsored

CDC respiratory virus guidance

Ascend Media

Review recommendations and updates to help prevent illness.

April 10, 2025

Automated PAH screening improves outcomes

The advanced VEST algorithm assists in identifying high-risk patients for early diagnosis, treatment.

June 17, 2025

Shocking rate of pediatric pulmonary embolism

Data highlighting the elevated frequency of PEs in children shows it to be similar to adults.

June 11, 2025

Combination therapy boosts transplant-free survival outcomes

Patients with IPF and PH significantly benefited from antifibrotics and pulmonary vasodilators.

June 6, 2025

Sponsored

Pulmonary drug market forecast

Ascend Media

Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.

April 10, 2025

Nerandomilast slows lung function decline in pulmonary fibrosis patients

The investigational drug met the primary endpoint in parallel phase 3 trials but did not meet the secondary endpoint.

June 5, 2025

Boosting immunity with nasal vaccines

The alternative form of immunization could offer increased protection in the respiratory tract.

May 29, 2025

Fresh treatment option for two pulmonary diseases

The FDA’s approval of Yutrepia could help improve quality of life for patients with PAH and PH-ILD.

May 28, 2025

Previous Page

Page 2 of 20

Next Page

Most Popular

CHEST publishes new guideline on NSCLC management

Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab

Study points toward potential screening test for COPD

Telehealth, home oxygen therapy could reduce readmissions in COPD patients

Language barriers linked to poorer asthma outcomes

Ethris launches phase 2a clinical trial of mRNA candidate for asthma